Helpline800-723-9166
Donate MonthlyDonate
Advance Online
A person pouring pills into their hand from a prescription bottle.
Advance Online

FDA Approves ICOTYDE™

This is the first and only IL-23R targeted oral peptide to date.

March 18, 2026
Recent Advance ArticlesNPF Logo
Your Must-Try Scalp Psoriasis Hair Care Tips
NPF Logo
Understanding the NPF Psoriatic Arthritis Diagnostic Test Grant Outcomes
NPF Logo
9 Must-Have Lotions

Stay in the Know

Expert tips, can’t-miss events, and the latest news, straight to your inbox.

National Health Council Standards of ExcellenceCharity Navigator

Copyright © 1996-2026 National Psoriasis Foundation/USA


The National Psoriasis Foundation is a qualified 501(c)(3) EIN 93-0571472.


Duplication, rebroadcast, republication, or other use of content appearing on this website is prohibited without written permission of the National Psoriasis Foundation (NPF).


NPF does not endorse or accept any responsibility for the content of external websites.


NPF does not endorse any specific treatments or medications for psoriasis and psoriatic arthritis.

We use cookies to offer you a better experience and analyze our site traffic. By continuing to use this website, you consent to the use of cookies in accordance with our Privacy Policy.